Wenjie Lai

Mr. Wenjie Lai

School of pharmacy, Macau University of Science and Technology, Macau, Macao
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
HWHaobin Wei
Haobin Wei
ZCZhang Chen
Zhang Chen
WLWenjie Lai
Wenjie Lai
WWWenxian Wang
Wenxian Wang
XBXiqing Bian
Xiqing Bian
XLXinzhi Li
Xinzhi Li
Background: Portulaca oleracea L. (PO) is an edible plant with a long medicinal history in traditional Chinese medicine for various inflammatory diseases, including skin disorders such as atopic dermatitis (AD). However, the anti-inflammatory effects and AD-alleviating mechanisms of PO remain unclear.Methods: PO aqueous extract was prepared from a water-soluble portion and then mixed with carbomer to obtain a hydrogel, which provided stable drug permeation and absorption in mouse skin. Amantadine acetate was identified as an abundant ingredient and further predicted to be a Janus kinase 1 (JAK1) inhibitor via molecular binding simulation. Mice with AD, established by repeated sensitization with 2,4-dinitrochlorobenzene (DNCB), were topically treated with PO hydrogel. Aurantiamide acetate was applied to HaCaT keratinocytes prior to inflammatory challenge in the presence or absence of JAK1-siRNA. Transcriptional and translational gene expressions associated with cutaneous inflammation or skin barriers were assessed by qPCR and Western blotting, respectively. Enzyme-linked immunosorbent assays were performed to detect immunoglobulin E and proinflammatory factors in skin tissue or serum. The phosphorylation of JAK1, signal transducer and activator of transcription (STAT)3, and STAT6 in keratinocytes and skin were analyzed by Western blotting.Results: In DNCB-sensitized mice, the PO hydrogel ameliorated skin lesions, lowered symptom scores, and reduced epidermal thickness by suppressing proinflammatory factor generation, oxidative stress, and the expression of CD4+. The PO hydrogel promoted the expression of caspase-14 and filaggrin, thereby helping restore skin barrier function in AD. The PO hydrogel and/or aurantiamide acetate inhibited the enzymatic activity of JAK1 and downstream (STAT)3/STAT6 signaling pathways in vitro and in vivo.Conclusion: PO significantly ameliorated skin lesions and restored epidermal barrier function in AD mice. This was achieved by suppressing JAK1 enzymatic activity and JAK1-mediated STAT signaling pathways.

11 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CZChuyun Zhao
Chuyun Zhao
WLWenjie Lai
Wenjie Lai
YLYu Li
Yu Li
KHKIN FONG HONG
KIN FONG HONG
Youhua XuYouhua Xu
Youhua Xu
The incidence and mortality of diabetes have increased dramatically in recent decades. New strategies to treat diabetes and its complications with minimal side effects are urgently needed. New monomeric molecules extracted from herbs are an alternative medicine that is being explored as candidate drugs for the treatment of diabetes and its complications. Nobiletin, a citrus flavonoid, has recently received increasing attention in scientific research due to its properties in combating diabetes and its complications, while existing research is scattered and unsystematic. This article summarizes recent studies and reviews the potential therapeutic role of nobiletin in preventing and alleviating diabetes and its complications, aiming to provide promising strategies for the clinical management of diabetes and its complications.

27 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LZLinsheng Zeng
Linsheng Zeng
WLWenjie Lai
Wenjie Lai
YLYueyang Li
Yueyang Li
MYMeiling Yang
Meiling Yang
JLJing Liang
Jing Liang
GTGuangdong Tong
Guangdong Tong
Chronic chikungunya arthritis (CCA) is a major long-term sequela of Chikungunya virus (CHIKV) infection. Its pathogenesis involves persistent viral reservoirs in joint tissues, metabolic reprogramming of myeloid cells, dysregulated Treg/Th17 immunity, and autoimmune-like tissue injury. This review integrates recent advances in virology, immunometabolism, and clinical pathology to propose a four-stage pathological cascade: “viral persistence”, “myeloid metabolic dysregulation”, “Treg/Th17 imbalance”, and “autoimmunity-like injury”. Key cytokine networks and molecular interactions at each stage are summarized. Based on this model, we outline stage-specific therapeutic strategies, including antiviral agents targeting Mxra8 or nsP1 (Stage I), metabolic modulators such as HIF-1α inhibitors and IL-1β blockade (Stage II), immune-restorative therapies such as low-dose IL-2 and CTLA-4-Ig (Stage III), and anti-inflammatory biologics or DMARDs for RA-like pathology (Stage IV). This framework provides a mechanistic basis for precision intervention and supports the development of biomarkers and clinical trial designs for CCA.

24 September 2025 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
XLXinzhi Li
Xinzhi Li
XXXiaobing Xu
Xiaobing Xu
WLWenjie Lai
Wenjie Lai
AJAi Jiang
Ai Jiang
NZNA ZHOU
NA ZHOU
YYYing Yu
Ying Yu
Prostanoids typically refer to prostaglandins, prostacyclin, and thromboxane, and are a series of bioactive lipid mediators primarily derived from arachidonic acid. Prostanoids play pivotal roles in various physiological processes, including liver repair and regeneration. Liver cells can produce different prostanoids, which can regulate multifaced functions in metabolic homeostasis, liver regeneration, and injury protection, through autocrine and paracrine mechanisms, preferably with the activation of specific receptors. Prostanoids orchestrate a complex network of cellular responses that promote liver repair and regeneration while modulating DNA replication, cellular proliferation, and hepatic inflammation. We reviewed prostanoid biosynthesis and intercellular interactions mediated by prostanoid receptors in the liver, focusing on their involvements in key signaling pathways that govern liver regeneration in response to partial hepatectomy, ischemia/reperfusion injury, and hepatotoxin/immunogen-induced damages. This review underscores the importance of prostanoids in liver homeostasis and highlights potential strategies for manipulating these pathways to improve clinical outcomes in liver repair and regeneration.